An Effective and Durable Option for Treating Major Depressive Disorder
Durability of TMS Treatments
NeuroStar TMS is the only TMS system with the durability of its effects established over 12 months.
In a trial with physician directed standard of care, meaning Neurostar TMS Therapy could be used in conjunction with antidepressants as needed, patients who had received treatment then reported their symptom levels at 3, 6, 9 and 12 months to determine the durability of their treatments. By the end of the 12-month period, 2 out of 3 patients who had either responded or completely remitted after TMS treatment remained at the symptom levels they reported at the end of the treatment phase.
After the end of the treatment period, only 1 in 3 patients needed to come back for maintenance TMS sessions, or ‘reintroduction’ during this 12-month period.
TMS Therapy Safety Tested Through Clinical Trials
Clinical trials have proven the safety of NeuroStar TMS Therapy in the treatment of patients with major depressive disorder and who have had an inadequate response to prior antidepressant medication.
Over 10,000 treatments were perform across NeuroStar clinical trials demonstrating its safety. NeuroStar TMS Therapy caused few side effects and was generally well tolerated by patients. The most common side effect reported during clinical trials was pain or discomfort at or near the treatment site. Please visit NeuroStar TMS to learn more.
Major Insurers Cover TMS Treatment, Including
The TMS Center of the Hudson Valley is the first established TMS treatment center in Poughkeepsie, New York and the Hudson Valley. Our mission is to provide personalized and effective TMS treatments for our patients.